跳至主要内容
临床试验/IRCT20090117001556N160
IRCT20090117001556N160尚未招募2 期

Dextromethorphan as an adjuvant therapy to sertraline in major depressive disorder: A randomized, double-blind, placebo-controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age between 18-65
  • Diagnosis of major depressive disorder based on DSM-V (score between 14 and 17).

排除标准

  • Serious suicidal thoughts
  • co-occurring psychiatric disorder such as bipolar disorder, schizophrenia
  • alcohol and drug use disorders
  • personality disorder
  • ECT in the last two months
  • thyroid problems
  • history of cardiovascular disease
  • autoimmune disease
  • active infection
  • neurological diseases (epilepsy, stroke, dementia), hematology, liver and kidney diseases
  • pregnancy and breastfeeding

研究者

相似试验